Systematic, spatial imaging of large multimolecular assemblies and the emerging principles of supramolecular order in biological systems

Journal of Molecular Recognition

Volumn 27, Issue 1, 2014, Pages 3-18

  Schubert, Walter ^a,b,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE   (Germany)

^c Human Toponome Project   (Germany)

Author keywords

fluorescence imaging; functional super resolution; imaging cycler; MELC; supermolecules; TIS; toponome; toponome imaging system

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; FUNCTIONAL SUPER-RESOLUTION; HUMAN; IMAGING CYCLER; MACROMOLECULE; MELC; MOLECULAR IMAGING; SUPERMOLECULES; TIS; TOPONOME; TOPONOME IMAGING SYSTEM;

FLUORESCENCE IMAGING; FUNCTIONAL SUPER-RESOLUTION; IMAGING CYCLER; MELC; SUPERMOLECULES; TIS; TOPONOME; TOPONOME IMAGING SYSTEM;

ANIMALS; HUMANS; MACROMOLECULAR SUBSTANCES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR IMAGING;

EID: 84891116512     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2326     Document Type: Conference Paper

References (81)

1. Abott A,. 2006. Mapping togetherness (research highlight, referring to Schubert et al. 2006). Nature 443: 608-609.
2. Ademmer K, Ebert M, Müller-Ostermeyer F, Friess H, Büchler MW, Schubert W, Malfertheiner P,. 1998. Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8 + CD18+ cells and CD8 + CD103+ cells by multi-epitope imaging. Clin. Exp. Immunol. 112 (1): 21-26.
3. Alex P, Gucek M, Li X,. 2009. Applications of proteomics in the study of inflammatory bowel diseases: current status and future directions with available technologies. Inflamm. Bowel Dis. 15 (4): 616-629.
4. Barclay AN, Birkeland ML, Brown MH, Beyers AD, Davis SJ, Somoza Ch, Williams AF,. 1993. The Leukocyte Antigen Facts Book. Academic Press: London.
5. Bedner E, Du L, Traganos F, Darzynkiewicz Z,. 2001. Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry. Cytometry 43 (1): 38-45.
6. Berndt U, Philipsen L, Bartsch S, Hu Y, Röcken C, Bertram W, Hämmerle M, Rösch T, Sturm A,. 2010. Comparative multi-epitope-ligand- cartography reveals essential immunological alterations in Barrett's metaplasia and esophageal adenocarcinoma. Mol. Cancer 9: 177.
7. Betzig E, Patterson GH, Sougrat R, Lindwasser OW, Olenych S, Bonifacino JS, Davidson MW, Lippincott-Schwartz J, Hess HF,. 2006. Imaging intracellular fluorescent proteins at nanometer resolution. Science 313 (5793): 1642-1645.
8. Bhattacharya S, Mathew G, Ruban E, Epstein DB, Krusche A, Hillert R, Schubert W, Khan M,. 2010. Toponome imaging system: in situ protein network mapping in normal and cancerous colon from the same patient reveals more than five-thousand cancer specific protein clusters and their subcellular annotation by using a three-symbol code. J. Proteome Res. 9 (12): 6112-6125.
9. Bode M, Irmler M, Friedenberger M, May C, Jung K, Stephan C, Meyer HE, Lach C, Hillert R, Krusche A, Beckers J, Marcus K, Schubert W,. 2008. Interlocking transcriptomics, proteomics and toponomics technologies for brain tissue analysis in murine hippocamapus. Proteomics 8 (6): 1170-8.
10. Bonnekoh B, Malykh Y, Böckelmann R, Bartsch S, Pommer AJ, Gollnick H,. 2006. Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopy. Eur. J. Dermatol. 16 (6): 623-635.
11. Bonnekoh B, Pommer AJ, Böckelmann R, Hofmeister H, Philipsen L, Gollnick H,. 2007a. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol. Physiol. 20 (5): 237-252.
12. Bonnekoh B, Böckelmann R, Pommer AJ, Malykh Y, Philipsen L, Gollnick H,. 2007b. The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by multi-epitope ligand cartography robot technology. Introduction of a novel biological drug-binding biochip assay. Skin Pharmacol. Physiol. 20 (2): 96-111.
13. Bonnekoh B, Pommer AJ, Böckelmann R, Philipsen L, Hofmeister H, Gollnick H,. 2008. In-situ-topoproteome analysis of cutaneous lymphomas: perspectives of assistance for dermatohistologic diagnostics by multi epitope ligand cartography (MELC). J. Dtsch. Dermatol. Ges. 6 (12): 1038-51.
14. Coste O, Brenneis C, Linke B, Pierre S, Maeurer C, Becker W, Schmidt H, Gao W, Geisslinger G, Scholich K,. 2008. Sphingosine 1-phosphate modulates spinal nociceptive processing. J. Biol. Chem. 283 (47): 32442-32451.
15. Cottingham K,. 2008. Human toponome project. J. Proteome Res. 7 (5): 1806.
16. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Cusella-De Angelis MG, Ponzetto C, Cossu G,. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell Biol. 147 (4): 869-878.
17. Dress A,. 2013a. Information Theory and Toponomics. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 1028-1030.
18. Dress A,. 2013b. Subset Surprisology and Toponomics. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2025-2027.
19. Dress A, Epstein D,. 2013. Topology and Toponomics. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2183-2185.
20. Dübel S, Stoevesandt O, Taussig MJ, Hust M,. 2010. Generating recombinant antibodies to the complete human proteome. Trends Biotechnol. 28 (7): 333-339.
21. Ebert MP, Ademmer K, Müller-Ostermeyer F, Friess H, Büchler MW, Schubert W, Malfertheiner P,. 1998. CD8 + CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am. J. Gastroenterol. 93 (11): 2141-2147.
22. Ecker RC, Tarnok A,. 2005. Cytomics goes 3D: toward tissomics. Cytometry A 65 (1): 1-3.
23. Ecker RC, Rogojanu R, Streit M, Oesterreicher K, Steiner GE,. 2006. An improved method for discrimination of cell populations in tissue sections using microscopy-based multicolor tissue cytometry. Cytometry A 69 (3): 119-123.
24. Eckhardt J, Ostalecki C, Kuczera K, Schuler G, Pommer AJ, Lechmann M,. 2013. Murine whole-organ immune cell populations revealed by multi-epitope-ligand cartography. J. Histochem. Cytochem. 61 (2): 125-133.
25. Evans RG, Naidu B, Rajpoot NM, Epstein D, Khan M,. 2012. Toponome imaging system: multiplex biomarkers in oncology. Trends Mol. Med. 18 (12): 723-31.
26. Eyerich K, Böckelmann R, Pommer AJ, Foerster S, Hofmeister H, Huss-Marp J, Cavani A, Behrendt H, Ring J, Gollnick H, Bonnekoh B, Traidl-Hoffmann C,. 2010. Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: cytotoxicity-dominated nickel versus pleiotrope pollen reaction. Exp. Dermatol. 19 (6): 511-517.
27. Fassbender K, Masters C, Beyreuther K,. 2000. Alzheimer's disease: an inflammatory disease? Neurobiol. Aging 21 (3): 433-436.
28. Friedenberger M, Bode M, Krusche A, Schubert W,. 2007. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system (TIS): sample preparation and measuring procedures. Nat. Protoc. 2 (9): 2285-94. (front cover story).
29. Gatenby R,. 2012. Perspective: finding cancer's first principles. Nature 491 (7425): S55.
30. Gieseler A,. 2013a. Cell Membrane Toponomics. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 364-366.
31. Gieseler A,. 2013b. Synaptic toponome. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2036-2038.
32. Haars R, Schneider A, Bode M, Schubert W,. 2000. Secretion and differential localization of the proteolytic cleavage products Abeta40 and Abeta42 of the Alzheimer amyloid precursor protein in human fetal myogenic cells. Eur. J. Cell Biol. 79 (6): 400-406.
33. Heinrich S, Salo-Ahen OMH, Huang B, Rippmann FF, Cruziani G, Wade RC,. 2010. Computational approaches to identifying and characterizing protein binding sites for ligand design. J. Mol. Recognit. 23 (2): 209-219.
34. Hell SW,. 2003. Toward fluorescence nanoscopy. Nat. Biotechnol. 21 (11): 1347-1355.
35. Hillert R,. 2013a. Combinatorial molecular phenotypes (CMPs). In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 440-441.
36. Hillert R,. 2013b. Toponome analysis. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2188-2191.
37. Hutchinson L, Kirck R,. 2011. High drug attrition rates-where are we going wrong? Nat. Rev. Clin. Oncol. 8 (4): 189-190.
38. James JR, McColl J, Oliveira MI, Dunne PD, Huang E, Jansson A, Nilsson P, Sleep DL, Gonçalves CM, Morgan SH, Felce JH, Mahen R, Fernandes RA, Carmo AM, Klenerman D, Davis SJ,. 2011. The T cell receptor triggering apparatus is composed of monovalent or monomeric proteins. J. Biol. Chem. 286 (37): 31993-2001.
39. Khan M, Waddington C,. 2013. Clinical aspects of the toponome imaging system (TIS). In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 412-414.
40. Krusche A,. 2013. TIS robot. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2172-2174.
41. Laffers W, Mittag A, Lenz D, Tárnok A, Gerstner AO,. 2006. Iterative restaining as a pivotal tool for n-color immunophenotyping by slide-based cytometry. Cytometry A 69 (3): 127-130.
42. Lehmann Brothers. 2001. The Fruits of Genomics. Lehman Brothers: New York.
43. Listing JB,. 1847. Vorstudien zur Topologie. Studien: Göttinger; 811-875.
44. McCarthy N, (editor in chief, no authors listed). 2013. Editorial: thoughts for a new year. Nat. Rev. Cancer 13 (1): 1.
45. Micheva KD, Bruchez MP,. 2012. The gain in brain: novel imaging techniques and multiplexed proteomic imaging of brain tissue ultrastructure. Curr. Opin. Neurobiol. 22 (1): 94-100.
46. Michor F, Liphardt J, Ferrari M, Widom J,. 2011. What does physics have to do with cancer? Nat. Rev. Cancer 11 (9): 657-670.
47. Mittag A, Lenz D, Gerstner AO, Tárnok A,. 2006. Hyperchromatic cytometry principles for cytomics using slide based cytometry. Cytometry A 69 (7): 691-703.
48. Murphy RF,. 2006. Putting proteins on the map. Nat. Biotechnol. 24 (10): 1223-1224.
49. O'Connor T, Wong HY,. 2012. Emergent properties. In The Stanford Encyclopedia of Philosophy (Spring 2012 Edition), Zalta EN, (ed). (http://plato.stanford.edu/archives/spr2012/entries/properties-emergent/)
50. Oeltze S, Freiler W, Hillert R, Doleisch H, Preim B, Schubert W,. 2011. Interactive, graph-based visual analysis of high-dimensional, multi-parameter fluorescence microscopy data in toponomics. IEEE Trans Vis Comput Graph. 17 (12): 1882-91.
51. Ostalecki C, Konrad A, Thurau E, Schuler G, Croner RS, Pommer AJ, Stürzl MA,. 2013. Combined multi-gene analysis at the RNA and protein levels in single FFPE tissue sections. Exp. Mol. Pathol. 95 (1): 1-6.
52. Richards FF, Konigsberg WH, Rosenstein RW, Varga JM,. 1975. On the specificity of antibodies. Science 187 (4172): 130-137.
53. Ruetze M, Gallinat S, Wenck H, Deppert W, Knott A,. 2010. In situ localization of epidermal stem cells using a novel multi epitope ligand cartography approach. Integr. Biol. (Camb). 2 (5-6): 241-249.
54. Rust MJ, Bates M, Zhuang X,. 2006. Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat. Methods 3 (10): 793-795.
55. Sage L,. 2009. The molecular face of prostate cancer. J. Proteome Res. 8 (6): 2616. (editorial to Schubert et al 2009)
56. Scannell JW, Blanckley A, Boldon H, Warrington B,. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11 (3): 191-200.
57. Schubert W,. 1990. Multiple antigen-mapping microscopy of human tissue. In Excerpta Medica, Burger G, Oberholzer M, Vooijs GP, (eds). Elsevier: Amsterdam. Adv Anal Cell Pathol; 97-98
58. Schubert W,. 1992. Antigenic determinants of T lymphocyte alpha beta receptor and other leukocyte surface proteins as differential markers of skeletal muscle regeneration: detection of spatially and timely restricted patterns by MAM microscopy. Eur. J. Cell Biol. 58 (2): 395-410.
59. Schubert W,. 1996. Automated device and method for measuring and identifying molecules or fragments thereof. European patent EP 01810428B1 (priority 29.5.1996, issued 2004).
60. Schubert W,. 2003. Topological proteomics, toponomics, MELK technology. Adv. Biochem. Eng. Biotechnol. 83: 198-209.
61. Schubert W,. 2006. Toponomanalyse. In Bioanalytik, 2rd edn, Lottspeich F, Engels JW, (eds). Spektrum Akademischer Verlag, Elsevier: Heidelberg; 1035-1048.
62. Schubert W,. 2007. A three-symbol code for organized proteomes based on cyclical imaging of protein locations. Cytometry A 71 (6): 352-60.
63. Schubert W,. 2010. On the origin of cell function encoded in the toponome. J. Biotechnol. 149 (4): 252-9.
64. Schubert W,. 2012a. Toponomanalyse. In Bioanalytik, 3rd edn, Lottspeich F, Engels JW, (eds). Springer Spektrum: Berlin, Heidelberg; 1140-1151
65. Schubert W,. 2012b. Treatment of chronic diseases. Is there a logic of failure? Dagstuhl Seminar "Structure Discovery in Biology: Motifs, Networks & Phylogenies", Dagstuhl castle, Germany, 15-20 July 2012.
66. Schubert W,. 2013. Toponomics. In Encyclopedia of Systems Biology, Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, (eds). Springer Science + Business Media: Berlin, Heidelberg; 2191-2212.
67. Schubert W, Zimmermann K, Cramer M, Starzinski-Powitz A,. 1989. Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 86 (1): 307-311.
68. Schubert W, Bonnekoh B, Pommer AJ, Philipsen L, Boeckelmann R, Malykh Y, Gollnick H, Friedenberger M, Bode M, Dress AW,. 2006. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat. Biotechnol. 24 (10): 1270-1278. (front cover story)
69. Schubert W, Friedenberger M, Bode M, Krusche A, Hillert R,. 2008. Functional architecture of the cell nucleus: towards comprehensive toponome reference maps of apoptosis. Biochim. Biophys. Acta 1783 (11): 2080-2088.
70. Schubert W, Gieseler A, Krusche A, Hillert R,. 2009. Toponome mapping in prostate cancer: detection of 2000 protein clusters in a single tissue section and cell type specific annotation by using a three-symbol code. J. Proteome Res. 8 (6): 2696-707.
71. Schubert W, Gieseler A, Krusche A, Serocka P, Hillert R,. 2012. Next-generation biomarkers based on 100-parameter functional super-resolution microscopy TIS. N. Biotechnol. 29 (5): 599-610.
72. Schubert W, de Wit NCJ, Walden P,. 2013. Systems biology of cancer. In Molecular Biology of Cancer, 2nd edn, Pelengaris S, Khan M, (eds). John Wiley & Sons: New York. (in press); 552-582.
73. Selkoe DJ,. 2011. Resolving controversies on path to Alzheimer's therapeutics. Nat. Med. 17 (9): 1060-1065.
74. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lõpez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG,. 2013. Genome responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110 (9): 3507-12. (www.pnas.org/cgi/doi/10.1073/pnas.1222878110)
75. Starkuviene V, Pepperkok R,. 2007. The potential of high-content highthroughput microscopy in drug discovery. Br. J. Pharmacol. 152 (1): 62-71.
76. Turro NJ,. 2005. Supramolecular structure and dynamics. Proc. Natl. Acad. Sci. U. S. A. 102 (31): 10765-10777.
77. Van Regenmortel MH,. 2004. Biological complexity emerges from the ashes of genetic reductionism. J. Mol. Recognit. 17 (3): 145-148.
78. Van Regenmortel MH,. 2012. Basic research in HIV vaccinology is hampered by reductionist thinking. Front. Immunol. 3: 194.
79. Wichmann HE, Kuhn KA, Waldenberger M, Schmelcher D, Schuffenhauer S, Meitinger T, Wurst SH, Lamla G, Fortier I, Burton PR, Peltonen L, Perola M, Metspalu A, Riegman P, Landegren U, Taussig MJ, Litton JE, Fransson MN, Eder J, Cambon-Thomsen A, Bovenberg J, Dagher G, van Ommen GJ, Griffith M, Yuille M, Zatloukal K,. 2011. Comprehensive catalog of European biobanks. Nat. Biotechnol. 29 (9): 795-797.
80. World Alzheimer Report. 2011. http://www.alz.co.uk/research/world-report- 2011 [06 May 2013]
81. Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, Cassino T, Gharaibeh B, Deasy BM, Huard J, Péault B,. 2007. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol. 25 (9): 1025-1034.